Literature DB >> 18352832

Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury.

Fengshan Yu1, Hiroshi Kamada, Kuniyasu Niizuma, Hidenori Endo, Pak H Chan.   

Abstract

Matrix metalloproteinase-9 (MMP-9) activation plays an important role in blood-brain barrier (BBB) dysfunction after central nervous system injury. Oxidative stress is also implicated in the pathogenesis after cerebral ischemia and spinal cord injury (SCI), but the relationship between MMP-9 activation and oxidative stress after SCI has not yet been clarified. We examined MMP-9 expression after SCI using copper/zinc-superoxide dismutase (SOD1) transgenic (Tg) rats. Our results show that MMP-9 activity significantly increased after SCI in both SOD1 Tg rats and their wild-type (Wt) littermates, although the increase was less in the SOD1 Tg rats. This pattern of MMP-9 expression was further confirmed by immunostaining and Western blot analysis. In situ zymography showed that gelatinolytic activity increased after SCI in the Wt rats, while the increase was less in the Tg rats. Evans blue extravasation increased in both the Wt and Tg rats, but was less in the SOD1 Tg rats. Inhibitor studies showed that, with an intrathecal injection of SB-3CT (a selective MMP-2/MMP-9 inhibitor), the MMP activity, Evans blue extravasation, and apoptotic cell death decreased after SCI. We conclude that increased oxidative stress after SCI leads to MMP-9 upregulation, BBB disruption, and apoptosis, and that overexpression of SOD1 in Tg rats decreases oxidative stress and further attenuates MMP-9 mediated BBB disruption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18352832      PMCID: PMC2365489          DOI: 10.1089/neu.2007.0438

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  29 in total

1.  Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury.

Authors:  R D Azbill; X Mu; A J Bruce-Keller; M P Mattson; J E Springer
Journal:  Brain Res       Date:  1997-08-15       Impact factor: 3.252

2.  Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.

Authors:  James Haorah; Servio H Ramirez; Kathy Schall; Daniel Smith; Rita Pandya; Yuri Persidsky
Journal:  J Neurochem       Date:  2007-01-23       Impact factor: 5.372

3.  Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.

Authors:  Hiroshi Kamada; Fengshan Yu; Chikako Nito; Pak H Chan
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

4.  Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury-induced brain trauma.

Authors:  Y Morita-Fujimura; M Fujimura; Y Gasche; J C Copin; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2000-01       Impact factor: 6.200

5.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine.

Authors:  V P Bindokas; J Jordán; C C Lee; R J Miller
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

6.  Role of neutrophils in spinal cord injury in the rat.

Authors:  Y Taoka; K Okajima; M Uchiba; K Murakami; S Kushimoto; M Johno; M Naruo; H Okabe; K Takatsuki
Journal:  Neuroscience       Date:  1997-08       Impact factor: 3.590

7.  Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.

Authors:  Yi Yang; Eduardo Y Estrada; Jeffrey F Thompson; Wenlan Liu; Gary A Rosenberg
Journal:  J Cereb Blood Flow Metab       Date:  2006-07-19       Impact factor: 6.200

8.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.

Authors:  S Rajagopalan; X P Meng; S Ramasamy; D G Harrison; Z S Galis
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

9.  Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures.

Authors:  E Bonfoco; D Krainc; M Ankarcrona; P Nicotera; S A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

10.  Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.

Authors:  Luca Cucullo; Pierre-Olivier Couraud; Babette Weksler; Ignacio-Andres Romero; Mohammed Hossain; Edward Rapp; Damir Janigro
Journal:  J Cereb Blood Flow Metab       Date:  2007-07-04       Impact factor: 6.200

View more
  47 in total

1.  The relationship between localized subarachnoid inflammation and parenchymal pathophysiology after spinal cord injury.

Authors:  James W Austin; Mehdi Afshar; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2012-07-01       Impact factor: 5.269

2.  Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury.

Authors:  Huaqing Liu; Veronica I Shubayev
Journal:  Exp Neurol       Date:  2011-07-02       Impact factor: 5.330

3.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

4.  Spinal Glia Division Contributes to Conditioning Lesion-Induced Axon Regeneration Into the Injured Spinal Cord: Potential Role of Cyclic AMP-Induced Tissue Inhibitor of Metalloproteinase-1.

Authors:  Huaqing Liu; Mila Angert; Tasuku Nishihara; Igor Shubayev; Jennifer Dolkas; Veronica I Shubayev
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

5.  Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo.

Authors:  Masataka Katsu; Kuniyasu Niizuma; Hideyuki Yoshioka; Nobuya Okami; Hiroyuki Sakata; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

6.  Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.

Authors:  Raquel Tonello; Sang Hoon Lee; Temugin Berta
Journal:  J Pain       Date:  2018-11-22       Impact factor: 5.820

7.  Selective gelatinase inhibitor neuroprotective agents cross the blood-brain barrier.

Authors:  Major Gooyit; Mark A Suckow; Valerie A Schroeder; William R Wolter; Shahriar Mobashery; Mayland Chang
Journal:  ACS Chem Neurosci       Date:  2012-07-30       Impact factor: 4.418

8.  Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.

Authors:  Hai-Tao Du; Ling-Ling Du; Xian-Ling Tang; Hong-Yan Ge; Ping Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-01       Impact factor: 3.117

Review 9.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

10.  Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-α, and matrix metalloproteinase-9 after spinal cord injury in mice.

Authors:  Lei Mao; Handong Wang; Liang Qiao; Xiaoliang Wang
Journal:  Mediators Inflamm       Date:  2010-08-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.